COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic Announces Additional Details Regarding the Issue of Shares to Johnson & Johnson Innovation - JJDC, Inc.

27/07/2017 - 08:05

COPENHAGEN, Denmark, July 27, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces additional details regarding the issue of shares to Johnson & Johnson Innovation - JJDC, Inc. ("J&J") in connection with [...]

Bavarian Nordic Announces Agreement with Janssen for the Development of Vaccine Regimens against HIV-1 and Hepatitis B

27/07/2017 - 08:00

Deal builds on ongoing collaboration to develop vaccines for Human Papillomavirus (HPV) and Ebola Total potential agreement value up to $879 million USD including upfront, equity investment and milestone payments [...]

Financière de Tubize SA: 2017 half-year financial report

27/07/2017 - 08:00

Press release 27 July 2017 Embargo till 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, day-to-day management, aspijcke@icloud.com 2017 half-year financial report [...]

Financière de Tubize SA: Rapport financier semestriel 2017

27/07/2017 - 08:00

Communiqué de presse 27 juillet 2017 Embargo jusqu'à 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, directeur, aspijcke@icloud.com Rapport financier semestriel [...]

Nestlé reports half-year results for 2017

27/07/2017 - 07:19

Follow today's event live 14:00 CEST Investor call audio webcast: http://edge.media-server.com/m/go/Nestle-2017-Half-year-results/lan/en/gb_custom_2/webcastViewerEn Full details: http://www.nestle.com/media/ [...]

VALNEVA et Emergent BioSolutions joignent leurs forces pour développer un vaccin contre le virus Zika

26/07/2017 - 22:15

Valneva et Emergent BioSolutions joignent leurs forces pour développer un vaccin contre le virus Zika Valneva accorde une licence mondiale exclusive à Emergent pour sa technologie de production de vaccin contre le virus [...]

VALNEVA and Emergent BioSolutions Join Forces to Develop a Vaccine against the Zika Virus

26/07/2017 - 22:15

Valneva and Emergent BioSolutions Join Forces to Develop a Vaccine against the Zika Virus Valneva grants Emergent an exclusive worldwide license for its Zika vaccine technology (ZIKV) Valneva and Emergent will co- [...]

Oriola Corporation - Repurchase of own shares on 26 July 2017

26/07/2017 - 17:47

ORIOLA CORPORATION STOCK EXCHANGE RELEASE 26 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 26 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 11 922 Average price/share, EUR 3,5615 Total [...]

Navamedic ASA: Presentation of second quarter figures

26/07/2017 - 14:52

Navamedic ASA invites you to follow an online presentation of the second quarter 2017 figures. The presentation will be webcasted at www.navamedic.com - investor relations - presentations - webcast on Friday 28.07 2017 [...]

Apricus Biosciences Announces Corporate Update and Second Quarter 2017 Financial Results Conference Call

26/07/2017 - 13:00

SAN DIEGO, July 26, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Apricus' second quarter [...]

Gap In Perceived and Actual Rates Of Prescription Stimulant Misuse, Abuse and Diversion Found Among College Students

26/07/2017 - 13:00

Gap In Perceived and Actual Rates Of Prescription S timulant Misuse, Abuse and Diversion Found Among College Students Preliminary analysis of data shows association between non-medical use of prescription stimulants and [...]

Midatech Pharma Plc: Completion of pre-clinical liver cancer programme

26/07/2017 - 13:00

26 July 2017 Midatech Pharma PLC ("Midatech", "Company" or "Group") Completion of pre-clinical liver cancer programme Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused [...]

Verona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment

26/07/2017 - 08:00

Dose escalation trial will evaluate RPL554 in approximately 400 COPD patients LONDON, July 26, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical [...]

ABLYNX RECEIVES FAST TRACK DESIGNATION FROM THE FDA FOR CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP

26/07/2017 - 07:00

GHENT, Belgium, 26 July 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for caplacizumab, the Company's first-in- [...]

Össur hf: Q2 Results 2017

25/07/2017 - 22:00

Announcement no. 52/2017 Interim report for the first six months of 2017 25 July 2017 Össur Q2 2017 highlights Sales amounted to USD 145 million compared to USD 139 million in Q2 2016, corresponding to 6% growth and 3% [...]

Medasys - Son expansion internationale soulignée par l'étude de marché KLAS

25/07/2017 - 18:38

Etude de renommée internationale, l'analyse menée par l'institut de recherche américain KLAS, porte sur l'acquisition et le déploiement des dossiers patients informatisés (DPI) à l'échelle mondiale (hors Etats-Unis). [...]

Corning and Stevanato Group Enter New Agreement to Supply New Corning Valor(TM) Glass to the Pharmaceutical Packaging Market

25/07/2017 - 18:21

Remarkable glass innovation enables enhanced quality parenteral packaging CORNING, N.Y., and PIOMBINO, DESE, PADUA, Italy; JULY 25, 2017 - Corning Incorporated (NYSE: GLW) and Stevanato Group announced today a new [...]

Oriola Corporation - Repurchase of own shares on 25 July 2017

25/07/2017 - 17:46

ORIOLA CORPORATION STOCK EXCHANGE RELEASE 25 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 25 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 13,485 Average price/share, EUR 3,5553 Total [...]

RedHill Biopharma Reports 2017 Second Quarter Financial Results

25/07/2017 - 13:20

RedHill maintains a debt-free balance sheet with $51 million cash 1 at the end of the second quarter of 2017 Select recent milestones include: Initial net revenues of approximately $0.5 million between June 12-30 [...]